I think W3 was alluding that CXO is near production. once up to nameplate will produce 160k average concentrate (1.2bn revenue if they achieve PLS pricing) and they are currently priced at 1.7bn market cap.
- Forums
- ASX - By Stock
- PLS
- PLS chart
PLS chart, page-13081
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.16 |
Change
-0.030(0.94%) |
Mkt cap ! $9.516B |
Open | High | Low | Value | Volume |
$3.17 | $3.19 | $3.06 | $50.14M | 15.97M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 49357 | $3.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.17 | 74794 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 49357 | 3.100 |
2 | 16000 | 3.090 |
4 | 4510 | 3.080 |
10 | 80282 | 3.060 |
12 | 568377 | 3.050 |
Price($) | Vol. | No. |
---|---|---|
3.170 | 74794 | 5 |
3.180 | 56600 | 5 |
3.190 | 131041 | 14 |
3.200 | 61350 | 20 |
3.210 | 38270 | 10 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online